Portfolio two is over 15 years old. The beneficiary contributed $8000 and the trustee $16,200 for a total of $24,200. The current value is $45,377 for a gain of $21,177 or 87%, for an annualized return of 7.1% adjusted for the timing of cash flows. You can see a summary at the link on the right or here.
This is an ETF portfolio, with 28% in cash, 11% in bonds (the BND ETF), and the remaining in US and worldwide equities.
2019 was a good year for the markets and this portfolio as well.
We have two ETF portfolios because it is difficult for these beneficiaries to hold individual stocks because of their professions. We moved Portfolio 2 to ETF’s several years ago and just sold the individual stocks in Portfolio 3 so that we can invest for Fall 2019 in “ETF mode”.
Portfolio two has the following ETF’s:
- VTI – the Vanguard all US market ETF
- VEU – the Vanguard all non-US market ETF
- HEFA – the “hedged” non-US market (so that it is not exposed to changes in currency rates)
- IAU – the ETF that tracks the price of gold
- Cash – the remaining dollars (40%) are in the Vanguard money market (VMMXX), which currently returns 2% / year
The decision for Fall 2019 is whether to keep this high cash allocation or to increase the allocation for equities.
Option One – keep current allocation
Option Two – add a bond ETF. Bond ETF’s go up when interest rates go down (as they have been doing). We could put $5000 in BND (Total bond market ETF)
Option Three – add $5000 to VWO which is the Emerging Markets ETF (broad) from Vanguard
Option Four – add an additional $5000 to VTI, which is the US stock market ETF
Options Two – Four can all be done since there is $17,367 in cash.
Portfolio Three has $24,561 in cash. We need to set up ETF’s for this portfolio and can broadly follow the same model as portfolio two.
- VTI – US market -30% of investment
- VEU / HEFA – 15% each (non US markets, with half hedged) for a total of 30%
- IAU – optional, could be 10%
- Cash or BND – could be 30%
These percentages could be changed as needed.
Portfolio Two is almost 15 years old. The beneficiary contributed $7500 and the trustee $15,200 for a total of $22,700. The current value is $40,221 for a gain of $17,521 or 77%, which is 6.9% / year when adjusted for the timing of cash flows. Go here or to the link on the right for details.
Portfolio two has switched to ETF’s which mostly track the US and world wide markets. This portfolio also has $12,932 in cash, which is almost 1/3 of the portfolio.
For this portfolio, the NASDAQ biotech index (IBB) is on watch.
Portfolio Two is over 14 years old. The beneficiary contributed $7500 and the trustee $15,200 for a total of $22,700. The current value is $38,227 for a gain of $15,527 or 68%, which is 6.3% / year when adjusted for the timing of cash flows. Go here or to the link on the right for details.
Portfolio two has switched to ETF’s which mostly track the US and world wide markets. This portfolio also has $12,568 in cash, which is almost 1/3 of the portfolio. The portfolio is doing OK in the current market downturn.
Portfolio two is almost 14 years old. The beneficiary contributed $7000 and the trustee $14,200 for a total of $21,200. The current balance is $39,012 for a gain of 84% or ~8% / year when adjusted for the timing of cash flows. You can see the detail here or at the link on the bottom.
This portfolio is unique because it has moved to ETF’s and ~ 25% cash position. The ETF’s have been doing well, with a large position in VTI (total US market) and a split between VEU (all world non US) and HEFA (all world non US hedged against the US dollar to get local market performance). There also is a small biotech position (IBB) and gold ETF position (IAU).
When we moved to ETF’s from individual stocks in 2016, we also purchased a 2 year CD which paid 1.55% interest, because our money market fund was essentially offering “zero” interest on our money and we wanted to keep about $10,000 or so in cash and yet get some sort of return on the money. This CD recently redeemed into cash in the account. We could buy a new CD, but we are currently getting 1.85% return in our money market so we can just leave it there because the 2 and 3 year CD’s aren’t offering much more than that, and interest rates seem more likely to go up than down. Thus we are planning (for now) to just leave cash in the money market instead of buying a CD because the incremental interest is negligible.
I want to have the beneficiary contribute now and have the trustee match, make our investments for summer 2018, have everything clear, then move the fund out of UTMA status and to the beneficiary (like we did with Portfolio One). Then we can give the (technically former) trustee “agency” capabilities so that we can still take advantage of my free trades (which apply to the accounts that are under me or I have agency capabilities for).
Portfolio Two is our second longest lived portfolio, at 13 1/2 years. This portfolio is unique because the individual stocks have been sold off and replaced with ETF’s and a CD. See the details here or at the link on the right.
The beneficiary has invested $7000 and the trustee $14,200 for a total of $21,200. The current value is $38,428 for a gain of $17,228 or 81%, which is 7.7% a year when adjusted for the time value of cash flows.
Walking through the detailed transactions often helps you to find items you’ve overlook – we noted that the biotech ETF IBB had a stock split (3-1) in December 2017 so I have been understating the value of this portfolio by almost $2000 since that time on my consolidated view.
There were no stock sales last year so the only tax impacted item is dividends which were approximately $632 during 2017.
The portfolio is doing well. It is interesting to see that the VEO ETF has returned 33% including dividends since we’ve owned it but the HEFA ETF has returned 19% including dividends… the difference is due to the 10% or so fall in the US dollar vs a basket of other world wide currencies. HEFA is hedged so you get returns in original currencies while VEO also includes the net effect of the dollar on returns (which magnified returns in this case).
Portfolio Two is our second longest lived portfolio. This portfolio has been converted to ETF’s and a CD. Beneficiary investment is $6500, trustee investment is $13,000 for a total of $19,500. Current value is $34,290 for a gain of $14,790 or 76%, which is 7.8% over the life of the fund annualized. Go here or to the link on the right for the portfolio detail.
This portfolio is different from the others in that there is a 1.55% CD for $10,000 and the rest are ETF’s. The largest ETF is VTI (US total index) with VEU (all world ex US) and HEFA (non US, hedged). We also have a small position in IBB for biotech. All seem to be doing well.
It is a symptom of ZIRP that our CD returns less than the US or European stock funds, which are around 2.5% / year.